---
title: "HAIMA AUTO: Hainan New Energy Sales will become a wholly-owned subsidiary of the company"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259022085.md"
description: "According to the Zhitong Finance APP, HAIMA AUTO announced that the company signed an \"Investment Agreement\" with Hainan Holdings and Hainan New Energy Sales on September 26, 2025, in Haikou City. The company will increase its investment in Hainan New Energy Sales by 408,164 yuan using its own funds. After the investment, the company's shareholding ratio in Hainan New Energy Sales will increase from 50% to 51%, and Hainan New Energy Sales will be included in the company's consolidated financial statements, becoming a subsidiary controlled by the company"
datetime: "2025-09-26T09:13:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259022085.md)
  - [en](https://longbridge.com/en/news/259022085.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259022085.md)
generator: "portal-rs"
---

# HAIMA AUTO: Hainan New Energy Sales will become a wholly-owned subsidiary of the company

According to the Zhitong Finance APP, HAIMA AUTO (000572.SZ) announced that the company signed an "Investment Agreement" with Hainan Holdings and Hainan New Energy Sales on September 26, 2025, in Haikou City. The company will increase its investment in Hainan New Energy Sales by 408,164 yuan using its own funds. After the investment, the company's shareholding ratio in Hainan New Energy Sales will increase from 50% to 51%, and Hainan New Energy Sales will be included in the company's consolidated financial statements, becoming a subsidiary controlled by the company

### Related Stocks

- [000572.CN](https://longbridge.com/en/quote/000572.CN.md)

## Related News & Research

- [Negative Link Announces Global Expansion and Next Phase of Growth](https://longbridge.com/en/news/296644416.md)
- [Here's Why We're Watching NOA Lithium Brines' (CVE:NOAL) Cash Burn Situation](https://longbridge.com/en/news/296350687.md)
- [FLU: Profit and EBITDA up on Malta growth and cost cuts, with 2026 guidance raised](https://longbridge.com/en/news/296306424.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [Motor racing-TWG Global says Cadillac F1 team and motorsport interests not for sale](https://longbridge.com/en/news/296524475.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**